Site intended for UK audience
Xiclav®

Xiclav®

Xiclav® contains the active substances amoxicillin and clavulanic acid.

Xiclav® is an antibiotic and works by killing bacteria that cause infections. Amoxicillin belongs to a group of medicines called “penicillins” which can sometimes become ineffective (inactive). The second active ingredient, clavulanic acid, prevents this.

Xiclav® is indicated for the treatment of the following infections:

  • middle ear infections and sinus infections,
  • respiratory infections
  • urinary tract infections
  • skin and soft tissue infections including dental infections
  • bone and joint infections

Children aged 6 years or younger should preferably be treated with Xiclav® powder for syrup.

  • Xiclav® film-coated tablets 625 mg, film-coated tablets 1 g Package Leaflet (German version), last revised 05.2023
  • Xiclav® powder for syrup 156,25 mg/5 ml Package Leaflet (German version), last revised 07.2023
  • Xiclav® powder for syrup 312,5 mg/5 ml Package Leaflet (German version), last revised 06.2023
  • Xiclav® powder for syrup duo 457 mg/5 ml Package Leaflet (German version), last revised 09.2023
  • Xiclav® Quicktab 625 mg, Quicktab 1 g Package Leaflet (German version), last revised 02.2024

Active substance: Amoxicillin, Clavulanic Acid

Strength Pack size
625 mg: 500 mg/125 mg 12
1 g: 875 mg/125 mg 10, 14
312,5 mg/5 ml: 250 mg/62,5 mg 100 ml
duo 457 mg/5 ml: 400 mg/57 mg 70, 140 ml
Quicktab 625 mg: 500 mg/125 mg 12
Quicktab 1 g: 875 mg/125 mg 10, 14

Downloads

Physicians / Pharmacists Login

We ask for your understanding that due to the Austrian Medicines Act, certain further information is only accessible to medical professionals.

Login Physicians / Pharmacists Login
Report adverse reactions